[April 22, 2014]

Research and Markets: Chronic Lymphocytic Leukemia Global Physician Survey - 2014 Edition

Research and Markets (http://www.researchandmarkets.com/research/3mdgf6/chronic) has announced the addition of the "Chronic Lymphocytic Leukemia Global Physician Survey - 2014" report to their offering.

The authors have conducted an extensive global survey of leading physicians in chronic lymphocytic leukemia to provide treatment insights and practice patterns. Physicians were selected based on their relevant publications and clinical trial experience in non-hodgkins lymphoma. The esearch study covered over 40 countries and over 150 treating physicians.

Information includes treatment by line of therapy, watch and wait patients, new therapy option usage, factors influencing treatment, future clinical interest and other NHL subtypes treated. The authors have partnered with several pharmaceutical firms assisting in protocol feasibility, clinical trial recruitment, physician profiling, recruitment analytics, competitive analysis, data mining and integration, and primary market research.

The authors always provide customizable strategic and analytical solutions. Their team consists of professionals with extensive pharmaceutical experience and advanced degrees in science and business.

Key Topics Covered:

1. Methodology
2. Respondents
3. Executive Summary
4. First-Line CLL Treatment
5. Second-Line CLL Treatment
6. Potential New Treatment Options
7. Factors Influencing Treatment
8. NHL Subtypes
9. Future Interest in NHL Clinical Trials and Surveys

For more information visit http://www.researchandmarkets.com/research/3mdgf6/chronic

[ Back To TMCnet.com's Homepage ]